Get the Stockscreener App
0.00
100.00%
-4.97
Bluebird Bio Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing, and commercializing potentially transformative gene therapies for severe genetic diseases.
See More
Previous Close:
$4.97
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$48.77M
Revenue:
$21.73M
Net Income/Loss:
$-91.17M
P/E Ratio:
0.00
EPS:
-0.74
Net Cash Flow:
$-286.43M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$15.40
Bluebird Bio Inc Stock (BLUE) Company Profile
Name
Bluebird Bio Inc
Sector
Industry
Phone
339-499-9300
Address
455 GRAND UNION BOULEVARD, SOMERVILLE, MA
Compare BLUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLUE
Bluebird Bio Inc
|
0.00 | 48.77M | 21.73M | -91.17M | -286.43M | -0.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.21 | 101.15B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.14 | 61.07B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.59 | 59.35B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.83 | 46.29B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.27 | 35.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Bluebird Bio Inc Stock (BLUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Nov-15-24 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-15-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-11-23 | Downgrade | HSBC Securities | Hold → Reduce |
| Dec-08-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Oct-17-23 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-01-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Apr-28-23 | Initiated | JP Morgan | Overweight |
| Mar-07-23 | Initiated | Robert W. Baird | Outperform |
| Aug-05-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-02-22 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-06-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-07-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-08-21 | Reiterated | Barclays | Equal Weight |
| Nov-08-21 | Reiterated | Canaccord Genuity | Hold |
| Nov-08-21 | Downgrade | Goldman | Neutral → Sell |
| Nov-08-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-08-21 | Reiterated | RBC Capital Mkts | Sector Perform |
| Nov-08-21 | Reiterated | Wedbush | Neutral |
| Nov-08-21 | Reiterated | Wells Fargo | Equal Weight |
| Aug-10-21 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-10-21 | Downgrade | Goldman | Buy → Neutral |
| Aug-10-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-10-21 | Resumed | William Blair | Mkt Perform |
| Aug-09-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Mar-10-21 | Upgrade | Mizuho | Neutral → Buy |
| Feb-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-16-21 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-16-21 | Downgrade | Wedbush | Outperform → Neutral |
| Feb-16-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-20 | Downgrade | Maxim Group | Buy → Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Nov-05-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Nov-05-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-05-20 | Downgrade | Stifel | Buy → Hold |
| Nov-02-20 | Upgrade | William Blair | Mkt Perform → Outperform |
| Oct-20-20 | Initiated | Mizuho | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-27-20 | Upgrade | Stifel | Hold → Buy |
| Feb-19-20 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-03-20 | Resumed | BofA/Merrill | Buy |
| Feb-03-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-19 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-26-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Nov-19-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-04-19 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-01-19 | Initiated | Stifel | Hold |
| Aug-12-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-18-19 | Upgrade | Maxim Group | Hold → Buy |
View All
Bluebird Bio Inc Stock (BLUE) Latest News
Jobs Data: Is bluebird bio Inc stock trending bullishJuly 2025 News Drivers & Technical Buy Zone Confirmation - خودرو بانک
Death Cross: Does bluebird bio Inc. have strong fundamentals2025 Market Trends & Safe Investment Capital Preservation Plans - خودرو بانک
Short Covering: Is bluebird bio Inc being accumulated by smart money2025 Market Trends & Reliable Intraday Trade Alerts - خودرو بانک
Portfolio Recap: Is bluebird bio Inc a good ESG investment2025 Market Sentiment & Stock Timing and Entry Methods - خودرو بانک
bluebird bio says seeking more cash to achieve cash flow break-even - MSN
Adeno Associated Virus (AVV) Vectors In Gene Therapy Market - openPR.com
Real time social sentiment graph for bluebird bio Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Key metrics from bluebird bio Inc.’s quarterly dataStop Loss & Weekly Top Stock Performers List - Newser
Does bluebird bio Inc. have strong fundamentalsGap Up & Daily Entry Point Trade Alerts - خودرو بانک
Analyzing drawdowns of bluebird bio Inc. with statistical toolsJuly 2025 Trends & Stock Portfolio Risk Management - Newser
Can bluebird bio Inc. outperform in the next rallyQuarterly Trade Review & Weekly Watchlist for Consistent Profits - خودرو بانک
bluebird bio Inc. stock volume spike explainedWeekly Trading Summary & Consistent Return Investment Signals - Newser
Risk vs reward if holding onto bluebird bio Inc.Portfolio Risk Report & Safe Entry Zone Tips - Newser
Technical analysis overview for bluebird bio Inc. stockJuly 2025 Sentiment & Technical Confirmation Alerts - Newser
Can trapped investors hope for a rebound in bluebird bio Inc.2025 Big Picture & Weekly High Return Opportunities - Newser
Published on: 2025-09-05 06:20:06 - Newser
Comparing bluebird bio Inc. in custom built stock radarsLong Setup & Real-Time Volume Spike Alerts - Newser
Top chart patterns to watch in bluebird bio Inc.July 2025 Momentum & AI Powered Market Trend Analysis - Newser
Detecting price anomalies in bluebird bio Inc. with AITrade Risk Summary & Weekly Top Gainers Trade List - Newser
What indicators show strength in bluebird bio Inc.Market Performance Summary & Risk Managed Trade Strategies - Newser
Analyzing net buyer seller activity in bluebird bio Inc.July 2025 Institutional & Long-Term Investment Growth Plans - Newser
Applying sector rotation models to bluebird bio Inc.Day Trade & AI Powered Market Trend Analysis - Newser
What to do if you’re stuck in bluebird bio Inc.Market Growth Review & Weekly Return Optimization Alerts - Newser
Published on: 2025-09-03 04:16:36 - Newser
What moving averages say about bluebird bio Inc.July 2025 Decliners & Accurate Technical Buy Alerts - Newser
Tick level data insight on bluebird bio Inc. volatilityJuly 2025 Spike Watch & Low Risk High Win Rate Picks - Newser
How to build a custom watchlist for bluebird bio Inc.July 2025 Levels & Accurate Intraday Trading Signals - Newser
Intraday pattern recognizer results for bluebird bio Inc.July 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Will bluebird bio Inc. stock recover after earningsRisk Management & Long-Term Capital Growth Ideas - خودرو بانک
Returns Recap: Does bluebird bio Inc. have pricing powerMarket Performance Recap & Detailed Earnings Play Alerts - خودرو بانک
What candlestick patterns are forming on bluebird bio Inc.Trade Entry Summary & Daily Growth Stock Investment Tips - Newser
Rally Mode: Can bluebird bio Inc. benefit from deglobalizationJuly 2025 Reactions & Accurate Intraday Trade Tips - خودرو بانک
Technical signs of recovery in bluebird bio Inc.2025 Year in Review & Weekly Top Gainers Alerts - Newser
Bluebird Bio Inc Stock (BLUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.33%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):